Under Paul Williams‘ leadership, the team at Lewis Silkin advises pharma, biotech and medical devices companies across patent disputes and litigation, IP portfolios and commercial agreements.
Legal 500 redaktioneller Kommentar
Anwält*innen
Firms to watch